By Ben Hirschler LONDON | Mon Nov 5, 2012 3:43am EST LONDON (Reuters) – International drug companies have offered to cap the total amount the Greek government has to pay for its medicines in a bid to resolve a crisis that is jeopardizing both the supply of drugs to patients and drugmakers’ profits. The proposal was set out by the trade group the European Federation of Pharmaceutical Industries and Associations (Efpia) in a letter to the Greek ministers of health and finance, a copy of which was seen by Reuters
ZURICH | Mon Nov 5, 2012 1:24am EST ZURICH (Reuters) – Novartis said on Monday its drug Votubia had received approval from the European Commission for treating non-cancerous kidney tumors in patients with a rare genetic disease known as tuberous sclerosis complex (TSC). This marks the first approval of a medical treatment in this patient population in Europe, Novartis said
